Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain

NCT01466764 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Due to inability to demonstrate benefit in this patient population.

Conditions

Pain
Inflammation

Interventions

DRUG: Anakinra
OTHER: Normal Saline

Sponsor

Stanford University